other

Updated:

Tactile Systems Technology Inc.

Tactile Systems Technology Inc. (TCMD) is a publicly traded Minneapolis-based firm developing pneumatic compression devices for lymphedema and venous ulcers.

Tactile Systems Technology Inc. logo

Tactile Systems Technology Inc.

Tactile Systems Technology, Inc |

General information

Firm type

other

Location

Region

North America

Country

United States

City

Minneapolis

Corporate office

Minneapolis, MN, United States

Sector focus

Healthcare ServicesDigital Health

Frequently asked questions

Who runs investment decisions at Tactile Systems Technology Inc.?

As a publicly traded company, capital allocation is managed by the executive team led by CEO Sherri Ferstler and the board of directors. Tactile does not operate as a family office or asset manager, so investment decisions are corporate — focused on R&D, sales force expansion, and potential acquisitions. The company's SEC filings detail these allocations.

How does Tactile Systems Technology generate its revenue?

Tactile generates revenue primarily through the sale and rental of its pneumatic compression devices, such as Flexitouch and Entre systems, along with associated supplies and service. Reimbursement from Medicare and private insurers for home-use lymphedema treatment drives the bulk of revenue. The company reports this in its annual 10-K filings.

Is Tactile Systems Technology related to any family office or venture firm?

No. Tactile Systems Technology Inc. is a publicly traded medical device company with no disclosed affiliation with any family office. Its primary investors are institutional shareholders and public market participants. The firm's structure is corporate, not fiduciary.

What investment stages does Tactile Systems Technology typically target?

Tactile does not operate as an investment firm. Its capital deployment is corporate — internal R&D, commercial expansion, and manufacturing. As a public company, it does not target investment stages in the venture or private equity sense.

Which sectors does Tactile Systems Technology explicitly avoid?

Tactile explicitly focuses on the medical device subsector of compression therapy for chronic vascular and lymphatic conditions. It does not engage in pharmaceuticals, diagnostics, or other med-tech verticals like cardiac or orthopedic devices. This focus is evident from its product portfolio and SEC disclosures.

How is Tactile Systems Technology related to the parent company or other entities?

Tactile Systems Technology Inc. is an independent publicly traded company with no parent entity. It has no disclosed spinout or subsidiary relationships beyond standard operating subsidiaries listed in SEC filings. There is no family-office or conglomerate ownership.

Does Tactile Systems Technology maintain philanthropic structures?

Tactile Systems Technology has not publicly disclosed a separate charitable foundation. The company has supported patient advocacy groups for lymphedema awareness through corporate partnerships, but these are not formal philanthropic vehicles. No separate 501(c)(3) entity has been identified in public records.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Minneapolis other profiles